Beta Bionics, Inc.
BBNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $30,432 | $26,566 | $27,675 |
| Short-Term Investments | $73,143 | $70,179 | $0 |
| Receivables | $11,996 | $4,448 | $0 |
| Inventory | $13,320 | $1,245 | $0 |
| Other Curr. Assets | $4,032 | $1,183 | $792 |
| Total Curr. Assets | $132,923 | $103,621 | $28,467 |
| Property Plant & Equip (Net) | $11,421 | $6,198 | $6,867 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $5,301 | $221 | $193 |
| Total NC Assets | $16,722 | $6,419 | $7,060 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $149,645 | $110,040 | $35,527 |
| Liabilities | – | – | – |
| Payables | $2,852 | $1,166 | $430 |
| Short-Term Debt | $1,529 | $1,224 | $976 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $939 | $0 | $0 |
| Other Curr. Liab. | $15,828 | $8,215 | $7,467 |
| Total Curr. Liab. | $21,148 | $10,605 | $8,873 |
| LT Debt | $5,726 | $2,999 | $3,157 |
| Deferred Rev, NC | $1,860 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $44,898 | $37,828 | $10,497 |
| Total NC Liab. | $52,484 | $40,827 | $13,654 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $7,255 | $4,223 | $4,133 |
| Total Liabilities | $73,632 | $51,432 | $22,527 |
| Equity | – | – | – |
| Pref Stock | $321,373 | $261,713 | $183,034 |
| Common Stock | $1 | $1 | $1 |
| Retained Earnings | -$296,737 | -$229,664 | -$185,565 |
| AOCI | $65 | $137 | $0 |
| Other Equity | $51,311 | $26,421 | $15,530 |
| Total Equity | $76,013 | $58,608 | $13,000 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $149,645 | $110,040 | $35,527 |
| Net Debt | -$23,177 | -$22,343 | -$23,542 |